Literature DB >> 33647885

The networks of m6A-SARS-CoV-2 related genes and immune infiltration patterns in idiopathic pulmonary fibrosis.

Xinyu Li1,2, Cheng Peng3, Ziqing Zhu2, Haozheng Cai1, Quan Zhuang1,4.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with a poor prognosis. The current coronavirus disease 2019 (COVID-19) shares some similarities with IPF. SARS-CoV-2 related genes have been reported to be broadly regulated by N6-methyladenosine (m6A) RNA modification. Here, we identified the association between m6A methylation regulators, COVID-19 infection pathways, and immune responses in IPF. The characteristic gene expression networks and immune infiltration patterns of m6A-SARS-CoV-2 related genes in different tissues of IPF were revealed. We subsequently evaluated the influence of these related gene expression patterns and immune infiltration patterns on the prognosis/lung function of IPF patients. The IPF cohort was obtained from the Gene Expression Omnibus dataset. Pearson correlation analysis was performed to identify the correlations among genes or cells. The CIBERSORT algorithm was used to assess the infiltration of 22 types of immune cells. The least absolute shrinkage and selection operator (LASSO) and proportional hazards model (Cox model) were used to develop the prognosis prediction model. Our research is pivotal for further understanding of the cellular and genetic links between IPF and SARS-CoV-2 infection in the context of the COVID-19 pandemic, which may contribute to providing new ideas for prognosis assessment and treatment of both diseases.

Entities:  

Keywords:  COVID-19; N6-methyladenosine; SARS-CoV-2; idiopathic pulmonary fibrosis; immune; prognosis

Mesh:

Substances:

Year:  2021        PMID: 33647885      PMCID: PMC7993677          DOI: 10.18632/aging.202725

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  41 in total

1.  Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.

Authors:  Ling Lei; Cheng Zhao; Fang Qin; Zhi-Yi He; Xu Wang; Xiao-Ning Zhong
Journal:  Clin Exp Rheumatol       Date:  2016-01-11       Impact factor: 4.473

2.  BRD4 mediates NF-κB-dependent epithelial-mesenchymal transition and pulmonary fibrosis via transcriptional elongation.

Authors:  Bing Tian; Yingxin Zhao; Hong Sun; Yueqing Zhang; Jun Yang; Allan R Brasier
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-28       Impact factor: 5.464

3.  Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway.

Authors:  Malgorzata Wygrecka; Bhola K Dahal; Djuro Kosanovic; Frank Petersen; Brigitte Taborski; Susanne von Gerlach; Miroslava Didiasova; Dariusz Zakrzewicz; Klaus T Preissner; Ralph T Schermuly; Philipp Markart
Journal:  Am J Pathol       Date:  2013-04-04       Impact factor: 4.307

4.  Profibrotic effect of IL-9 overexpression in a model of airway remodeling.

Authors:  Sybille van den Brûle; Julie Heymans; Xavier Havaux; Jean-Christophe Renauld; Dominique Lison; François Huaux; Olivier Denis
Journal:  Am J Respir Cell Mol Biol       Date:  2007-04-19       Impact factor: 6.914

5.  Mast cells: a pivotal role in pulmonary fibrosis.

Authors:  Arul Veerappan; Nathan J O'Connor; Jacqueline Brazin; Alicia C Reid; Albert Jung; David McGee; Barbara Summers; Dascher Branch-Elliman; Brendon Stiles; Stefan Worgall; Robert J Kaner; Randi B Silver
Journal:  DNA Cell Biol       Date:  2013-04       Impact factor: 3.311

6.  RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis.

Authors:  K L Watts; E Cottrell; P R Hoban; M A Spiteri
Journal:  Respir Res       Date:  2006-06-15

7.  Anti-asialo GM1 NK cell depleting antibody does not alter the development of bleomycin induced pulmonary fibrosis.

Authors:  Justin Monnier; Brian A Zabel
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

Review 8.  Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.

Authors:  Peter M George; Athol U Wells; R Gisli Jenkins
Journal:  Lancet Respir Med       Date:  2020-05-15       Impact factor: 30.700

9.  N6-methyladenosine modification enables viral RNA to escape recognition by RNA sensor RIG-I.

Authors:  Mijia Lu; Zijie Zhang; Miaoge Xue; Boxuan Simen Zhao; Olivia Harder; Anzhong Li; Xueya Liang; Thomas Z Gao; Yunsheng Xu; Jiyong Zhou; Zongdi Feng; Stefan Niewiesk; Mark E Peeples; Chuan He; Jianrong Li
Journal:  Nat Microbiol       Date:  2020-02-03       Impact factor: 17.745

View more
  1 in total

1.  The Combined Model of CX3CR1-Related Immune Infiltration Genes to Evaluate the Prognosis of Idiopathic Pulmonary Fibrosis.

Authors:  Haozheng Cai; Shijie Chen; Xinyu Li; Hanying Liu; Ying Zhang; Quan Zhuang
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.